Barrett's esophagus: proton pump inhibitors and chemoprevention II.

Richter, J. E.; Penagini, R.; Tenca, A.; Pohl, D.; Dvorak, K.; Goldman, A.; Savarino, E.; Zentilin, P.; Savarino, V.; Watson, J. T.; R. K. H.,; Pace, F.; Casini, V.; Peura, D. A.; Herzig, S. J.; Kamiya, T.; Pelosini, I.; Scarpignato, C.; Armstrong, D.; Devault, K. R.; Bechi, Paolo; Taddei, Antonio; Freschi, Giancarlo; Ringressi, MARIA NOVELLA; Degli'Innocenti, D. R.; Castiglione, Francesca; Masini, Emanuela; Hunt, R. H.

doi:10.1111/j.1749-6632.2011.06048.x

The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

Barrett's esophagus: proton pump inhibitors and chemoprevention II / J. E. Richter;R. Penagini;A. Tenca;D. Pohl;K. Dvorak;A. Goldman;E. Savarino;P. Zentilin;V. Savarino;J. T. Watson;R. K. H;F. Pace;V. Casini;D. A. Peura;S. J. Herzig;T. Kamiya;I. Pelosini;C. Scarpignato;D. Armstrong;K. R. DeVault;P. Bechi;A. Taddei;G. Freschi;M. N. Ringressi;D. R. Degli'Innocenti;F. Castiglione;E. Masini;R. H. Hunt. - In: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. - ISSN 0077-8923. - ELETTRONICO. - 1232:(2011), pp. 114-139. [10.1111/j.1749-6632.2011.06048.x]